Additional file 6 of Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017

Additional file 6. Annual and cumulative DAA and HCV treatment among patients receiving OAT from 2014 to 2017. OAT = opioid agonist therapy, DAA = direct-acting antiviral agent, OR = odds ratio, aOR = adjusted odds ratio, CI = confidence interval. Source: The Norwegian Prescription Database (NorPD) and The Swedish Prescribed Drug Register (SPDR). *N05BA01, N05BA04, N05BA06, N05BA12, N05CD02, N05CD03, N05CD08, N03AE01. **N05CF01 and N05CF02. ***N03AA, N03AB, N03AF, N03AG, N03AX. ****N06AA, N06AB, N06AF, N06AG, N06AX. *****N05AA, N05AB, N05AC, N05AD, N05AE, N05AF, N05AG, N05AH, N05AL, N05AN, N05AX. For ATC codes see additional file 4